TNF Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNFA and other ETFs, options, and stocks.

About TNFA

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. 

CEO
Christopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees
2
Employees2
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1989
Founded1989
Employees
2
Employees2

TNFA Key Statistics

Market cap
1.60M
Market cap1.60M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
4.72M
Average volume4.72M
High today
$0.12
High today$0.12
Low today
$0.1101
Low today$0.1101
Open price
$0.12
Open price$0.12
Volume
165.29K
Volume165.29K
52 Week high
$1.95
52 Week high$1.95
52 Week low
$0.1008
52 Week low$0.1008

People also own

Based on the portfolios of people who own TNFA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.